CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 59 enrolled
Drug / intervention
Hyaluronic acid +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03967444
NCT03967444N/ACompleted

Post Marketing Study to Evaluate Lip Augmentation & Satisfaction With Restylane Kysse

Galderma R&D·interventional·Posted May 30, 2019·Updated Aug 26, 2022

In Brief

A clinical study evaluating Hyaluronic acid for Lip Augmentation. Completed, enrolled 59 participants across 2 sites.

Detailed Summary

Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Kysse.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMay 30, 2019
Enrollment StartMay 29, 2019
Primary CompletionSep 18, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7.1 years ago

Interventions

Hyaluronic aciddevice

Injectable gel for lip augmentation

Hyaluronic aciddevice

Injectable gel. Lip Augmentation and other wrinkles/folds